Dr Horton Stock EBITDA
| D1HI34 Stock | BRL 975.80 16.35 1.70% |
DR Horton fundamentals help investors to digest information that contributes to DR Horton's financial success or failures. It also enables traders to predict the movement of D1HI34 Stock. The fundamental analysis module provides a way to measure DR Horton's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DR Horton stock.
D1HI34 |
DR Horton Company EBITDA Analysis
DR Horton's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current DR Horton EBITDA | 7.65 B |
Most of DR Horton's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DR Horton is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, DR Horton reported earnings before interest,tax, depreciation and amortization of 7.65 B. This is much higher than that of the Consumer Cyclical sector and significantly higher than that of the Residential Construction industry. The ebitda for all Brazil stocks is 96.28% lower than that of the firm.
D1HI34 EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DR Horton's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DR Horton could also be used in its relative valuation, which is a method of valuing DR Horton by comparing valuation metrics of similar companies.DR Horton is rated # 5 in ebitda category among its peers.
D1HI34 Fundamentals
| Return On Equity | 0.31 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 179.36 B | |||
| Shares Outstanding | 343.39 M | |||
| Price To Earning | 10.55 X | |||
| Price To Book | 1.50 X | |||
| Price To Sales | 4.76 X | |||
| Revenue | 33.48 B | |||
| Gross Profit | 10.07 B | |||
| EBITDA | 7.65 B | |||
| Net Income | 5.86 B | |||
| Cash And Equivalents | 2.11 B | |||
| Cash Per Share | 5.86 X | |||
| Total Debt | 6.07 B | |||
| Debt To Equity | 0.34 % | |||
| Current Ratio | 5.29 X | |||
| Book Value Per Share | 58.71 X | |||
| Cash Flow From Operations | 561.8 M | |||
| Earnings Per Share | 83.76 X | |||
| Number Of Employees | 13.24 K | |||
| Beta | 1.53 | |||
| Market Capitalization | 181.57 B | |||
| Total Asset | 30.35 B | |||
| Z Score | 18.4 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 30.35 B | |||
| Last Dividend Paid | 0.93 |
About DR Horton Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DR Horton's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DR Horton using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DR Horton based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in D1HI34 Stock
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade D1HI34 Stock refer to our How to Trade D1HI34 Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.